世界の下垂体がん市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pituitary Cancer Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4628 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、下垂体がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血液検査、尿検査、脳画像検査、視力検査）、用途別市場規模（病院、診療所、診断センター、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・下垂体がんの市場動向 ・企業の競争状況、市場シェア ・下垂体がんの種類別市場規模（血液検査、尿検査、脳画像検査、視力検査） ・下垂体がんの用途別市場規模（病院、診療所、診断センター、研究機関） ・下垂体がんの北米市場規模2016-2027（アメリカ、カナダ） ・下垂体がんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・下垂体がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・下垂体がんの中南米市場規模2016-2027（メキシコ、ブラジル） ・下垂体がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Trinity Biotech、Salzman、Genentech、Sigma-Aldrich、Varian Medical Systems、Elekta、Accuray Incorporated、Ion Beam Applications、Nordion、C. R. Bard、Isoray Medical、RaySearch Laboratories、Mevion Medical Systems、Mitsubishi Electric） ・結論

Pituitary adenomas are tumors that occur in the pituitary gland. Pituitary adenomas are generally divided into three categories dependent upon their biological functioning: benign adenoma, invasive adenoma, and carcinomas. Most adenomas are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general population is approximately 17%.
While pituitary adenomas are common, affecting approximately one in 6 of the general population, clinically active pituitary adenomas that require surgical treatment are more rare, affecting approximately one in 1000 of the general population.

Market Analysis and Insights: Global Pituitary Cancer Market
The global Pituitary Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pituitary Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pituitary Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pituitary Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pituitary Cancer market.

Global Pituitary Cancer Scope and Market Size
Pituitary Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pituitary Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Blood Tests
Urine Test
Brain Imaging
Vision Testing

Segment by Application
Hospital
Clinics
Diagnostic Centers
Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Trinity Biotech
Salzman
Genentech
Sigma-Aldrich
Varian Medical Systems
Elekta
Accuray Incorporated
Ion Beam Applications
Nordion
Sigma-Aldrich
Varian Medical Systems
RaySearch Laboratories

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pituitary Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Tests
1.2.3 Urine Test
1.2.4 Brain Imaging
1.2.5 Vision Testing
1.3 Market by Application
1.3.1 Global Pituitary Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.3.5 Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pituitary Cancer Market Perspective (2016-2027)
2.2 Pituitary Cancer Growth Trends by Regions
2.2.1 Pituitary Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pituitary Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Pituitary Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Pituitary Cancer Industry Dynamic
2.3.1 Pituitary Cancer Market Trends
2.3.2 Pituitary Cancer Market Drivers
2.3.3 Pituitary Cancer Market Challenges
2.3.4 Pituitary Cancer Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pituitary Cancer Players by Revenue
3.1.1 Global Top Pituitary Cancer Players by Revenue (2016-2021)
3.1.2 Global Pituitary Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Pituitary Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pituitary Cancer Revenue
3.4 Global Pituitary Cancer Market Concentration Ratio
3.4.1 Global Pituitary Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pituitary Cancer Revenue in 2020
3.5 Pituitary Cancer Key Players Head office and Area Served
3.6 Key Players Pituitary Cancer Product Solution and Service
3.7 Date of Enter into Pituitary Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pituitary Cancer Breakdown Data by Type
4.1 Global Pituitary Cancer Historic Market Size by Type (2016-2021)
4.2 Global Pituitary Cancer Forecasted Market Size by Type (2022-2027)

5 Pituitary Cancer Breakdown Data by Application
5.1 Global Pituitary Cancer Historic Market Size by Application (2016-2021)
5.2 Global Pituitary Cancer Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pituitary Cancer Market Size (2016-2027)
6.2 North America Pituitary Cancer Market Size by Type
6.2.1 North America Pituitary Cancer Market Size by Type (2016-2021)
6.2.2 North America Pituitary Cancer Market Size by Type (2022-2027)
6.2.3 North America Pituitary Cancer Market Size by Type (2016-2027)
6.3 North America Pituitary Cancer Market Size by Application
6.3.1 North America Pituitary Cancer Market Size by Application (2016-2021)
6.3.2 North America Pituitary Cancer Market Size by Application (2022-2027)
6.3.3 North America Pituitary Cancer Market Size by Application (2016-2027)
6.4 North America Pituitary Cancer Market Size by Country
6.4.1 North America Pituitary Cancer Market Size by Country (2016-2021)
6.4.2 North America Pituitary Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Pituitary Cancer Market Size (2016-2027)
7.2 Europe Pituitary Cancer Market Size by Type
7.2.1 Europe Pituitary Cancer Market Size by Type (2016-2021)
7.2.2 Europe Pituitary Cancer Market Size by Type (2022-2027)
7.2.3 Europe Pituitary Cancer Market Size by Type (2016-2027)
7.3 Europe Pituitary Cancer Market Size by Application
7.3.1 Europe Pituitary Cancer Market Size by Application (2016-2021)
7.3.2 Europe Pituitary Cancer Market Size by Application (2022-2027)
7.3.3 Europe Pituitary Cancer Market Size by Application (2016-2027)
7.4 Europe Pituitary Cancer Market Size by Country
7.4.1 Europe Pituitary Cancer Market Size by Country (2016-2021)
7.4.2 Europe Pituitary Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pituitary Cancer Market Size (2016-2027)
8.2 Asia-Pacific Pituitary Cancer Market Size by Type
8.2.1 Asia-Pacific Pituitary Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pituitary Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pituitary Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Pituitary Cancer Market Size by Application
8.3.1 Asia-Pacific Pituitary Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pituitary Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pituitary Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Pituitary Cancer Market Size by Region
8.4.1 Asia-Pacific Pituitary Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pituitary Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pituitary Cancer Market Size (2016-2027)
9.2 Latin America Pituitary Cancer Market Size by Type
9.2.1 Latin America Pituitary Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Pituitary Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Pituitary Cancer Market Size by Type (2016-2027)
9.3 Latin America Pituitary Cancer Market Size by Application
9.3.1 Latin America Pituitary Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Pituitary Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Pituitary Cancer Market Size by Application (2016-2027)
9.4 Latin America Pituitary Cancer Market Size by Country
9.4.1 Latin America Pituitary Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Pituitary Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pituitary Cancer Market Size (2016-2027)
10.2 Middle East & Africa Pituitary Cancer Market Size by Type
10.2.1 Middle East & Africa Pituitary Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pituitary Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pituitary Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Pituitary Cancer Market Size by Application
10.3.1 Middle East & Africa Pituitary Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pituitary Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pituitary Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Pituitary Cancer Market Size by Country
10.4.1 Middle East & Africa Pituitary Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pituitary Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Trinity Biotech
11.1.1 Trinity Biotech Company Details
11.1.2 Trinity Biotech Business Overview
11.1.3 Trinity Biotech Pituitary Cancer Introduction
11.1.4 Trinity Biotech Revenue in Pituitary Cancer Business (2016-2021)
11.1.5 Trinity Biotech Recent Development
11.2 Salzman
11.2.1 Salzman Company Details
11.2.2 Salzman Business Overview
11.2.3 Salzman Pituitary Cancer Introduction
11.2.4 Salzman Revenue in Pituitary Cancer Business (2016-2021)
11.2.5 Salzman Recent Development
11.3 Genentech
11.3.1 Genentech Company Details
11.3.2 Genentech Business Overview
11.3.3 Genentech Pituitary Cancer Introduction
11.3.4 Genentech Revenue in Pituitary Cancer Business (2016-2021)
11.3.5 Genentech Recent Development
11.4 Sigma-Aldrich
11.4.1 Sigma-Aldrich Company Details
11.4.2 Sigma-Aldrich Business Overview
11.4.3 Sigma-Aldrich Pituitary Cancer Introduction
11.4.4 Sigma-Aldrich Revenue in Pituitary Cancer Business (2016-2021)
11.4.5 Sigma-Aldrich Recent Development
11.5 Varian Medical Systems
11.5.1 Varian Medical Systems Company Details
11.5.2 Varian Medical Systems Business Overview
11.5.3 Varian Medical Systems Pituitary Cancer Introduction
11.5.4 Varian Medical Systems Revenue in Pituitary Cancer Business (2016-2021)
11.5.5 Varian Medical Systems Recent Development
11.6 Elekta
11.6.1 Elekta Company Details
11.6.2 Elekta Business Overview
11.6.3 Elekta Pituitary Cancer Introduction
11.6.4 Elekta Revenue in Pituitary Cancer Business (2016-2021)
11.6.5 Elekta Recent Development
11.7 Accuray Incorporated
11.7.1 Accuray Incorporated Company Details
11.7.2 Accuray Incorporated Business Overview
11.7.3 Accuray Incorporated Pituitary Cancer Introduction
11.7.4 Accuray Incorporated Revenue in Pituitary Cancer Business (2016-2021)
11.7.5 Accuray Incorporated Recent Development
11.8 Ion Beam Applications
11.8.1 Ion Beam Applications Company Details
11.8.2 Ion Beam Applications Business Overview
11.8.3 Ion Beam Applications Pituitary Cancer Introduction
11.8.4 Ion Beam Applications Revenue in Pituitary Cancer Business (2016-2021)
11.8.5 Ion Beam Applications Recent Development
11.9 Nordion
11.9.1 Nordion Company Details
11.9.2 Nordion Business Overview
11.9.3 Nordion Pituitary Cancer Introduction
11.9.4 Nordion Revenue in Pituitary Cancer Business (2016-2021)
11.9.5 Nordion Recent Development
11.10 C. R. Bard
11.10.1 C. R. Bard Company Details
11.10.2 C. R. Bard Business Overview
11.10.3 C. R. Bard Pituitary Cancer Introduction
11.10.4 C. R. Bard Revenue in Pituitary Cancer Business (2016-2021)
11.10.5 C. R. Bard Recent Development
11.11 Isoray Medical
11.11.1 Isoray Medical Company Details
11.11.2 Isoray Medical Business Overview
11.11.3 Isoray Medical Pituitary Cancer Introduction
11.11.4 Isoray Medical Revenue in Pituitary Cancer Business (2016-2021)
11.11.5 Isoray Medical Recent Development
11.12 RaySearch Laboratories
11.12.1 RaySearch Laboratories Company Details
11.12.2 RaySearch Laboratories Business Overview
11.12.3 RaySearch Laboratories Pituitary Cancer Introduction
11.12.4 RaySearch Laboratories Revenue in Pituitary Cancer Business (2016-2021)
11.12.5 RaySearch Laboratories Recent Development
11.13 Mevion Medical Systems
11.13.1 Mevion Medical Systems Company Details
11.13.2 Mevion Medical Systems Business Overview
11.13.3 Mevion Medical Systems Pituitary Cancer Introduction
11.13.4 Mevion Medical Systems Revenue in Pituitary Cancer Business (2016-2021)
11.13.5 Mevion Medical Systems Recent Development
11.14 Mitsubishi Electric
11.14.1 Mitsubishi Electric Company Details
11.14.2 Mitsubishi Electric Business Overview
11.14.3 Mitsubishi Electric Pituitary Cancer Introduction
11.14.4 Mitsubishi Electric Revenue in Pituitary Cancer Business (2016-2021)
11.14.5 Mitsubishi Electric Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pituitary Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Tests
Table 3. Key Players of Urine Test
Table 4. Key Players of Brain Imaging
Table 5. Key Players of Vision Testing
Table 6. Global Pituitary Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pituitary Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pituitary Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Pituitary Cancer Market Share by Regions (2016-2021)
Table 10. Global Pituitary Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Pituitary Cancer Market Share by Regions (2022-2027)
Table 12. Pituitary Cancer Market Trends
Table 13. Pituitary Cancer Market Drivers
Table 14. Pituitary Cancer Market Challenges
Table 15. Pituitary Cancer Market Restraints
Table 16. Global Pituitary Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Pituitary Cancer Market Share by Players (2016-2021)
Table 18. Global Top Pituitary Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pituitary Cancer as of 2020)
Table 19. Ranking of Global Top Pituitary Cancer Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Pituitary Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pituitary Cancer Product Solution and Service
Table 23. Date of Enter into Pituitary Cancer Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pituitary Cancer Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Pituitary Cancer Revenue Market Share by Type (2016-2021)
Table 27. Global Pituitary Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Pituitary Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Pituitary Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Pituitary Cancer Revenue Market Share by Application (2016-2021)
Table 31. Global Pituitary Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Pituitary Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Pituitary Cancer Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Pituitary Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Pituitary Cancer Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Pituitary Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Pituitary Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Pituitary Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Pituitary Cancer Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Pituitary Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Pituitary Cancer Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Pituitary Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Pituitary Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Pituitary Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pituitary Cancer Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pituitary Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pituitary Cancer Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pituitary Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pituitary Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Pituitary Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Pituitary Cancer Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Pituitary Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Pituitary Cancer Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Pituitary Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Pituitary Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Pituitary Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pituitary Cancer Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pituitary Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pituitary Cancer Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pituitary Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pituitary Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Pituitary Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 63. Trinity Biotech Company Details
Table 64. Trinity Biotech Business Overview
Table 65. Trinity Biotech Pituitary Cancer Product
Table 66. Trinity Biotech Revenue in Pituitary Cancer Business (2016-2021) & (US$ Million)
Table 67. Trinity Biotech Recent Development
Table 68. Salzman Company Details
Table 69. Salzman Business Overview
Table 70. Salzman Pituitary Cancer Product
Table 71. Salzman Revenue in Pituitary Cancer Business (2016-2021) & (US$ Million)
Table 72. Salzman Recent Development
Table 73. Genentech Company Details
Table 74. Genentech Business Overview
Table 75. Genentech Pituitary Cancer Product
Table 76. Genentech Revenue in Pituitary Cancer Business (2016-2021) & (US$ Million)
Table 77. Genentech Recent Development
Table 78. Sigma-Aldrich Company Details
Table 79. Sigma-Aldrich Business Overview
Table 80. Sigma-Aldrich Pituitary Cancer Product
Table 81. Sigma-Aldrich Revenue in Pituitary Cancer Business (2016-2021) & (US$ Million)
Table 82. Sigma-Aldrich Recent Development
Table 83. Varian Medical Systems Company Details
Table 84. Varian Medical Systems Business Overview
Table 85. Varian Medical Systems Pituitary Cancer Product
Table 86. Varian Medical Systems Revenue in Pituitary Cancer Business (2016-2021) & (US$ Million)
Table 87. Varian Medical Systems Recent Development
Table 88. Elekta Company Details
Table 89. Elekta Business Overview
Table 90. Elekta Pituitary Cancer Product
Table 91. Elekta Revenue in Pituitary Cancer Business (2016-2021) & (US$ Million)
Table 92. Elekta Recent Development
Table 93. Accuray Incorporated Company Details
Table 94. Accuray Incorporated Business Overview
Table 95. Accuray Incorporated Pituitary Cancer Product
Table 96. Accuray Incorporated Revenue in Pituitary Cancer Business (2016-2021) & (US$ Million)
Table 97. Accuray Incorporated Recent Development
Table 98. Ion Beam Applications Company Details
Table 99. Ion Beam Applications Business Overview
Table 100. Ion Beam Applications Revenue in Pituitary Cancer Business (2016-2021) & (US$ Million)
Table 101. Ion Beam Applications Recent Development
Table 102. Nordion Company Details
Table 103. Nordion Business Overview
Table 104. Nordion Pituitary Cancer Product
Table 105. Nordion Revenue in Pituitary Cancer Business (2016-2021) & (US$ Million)
Table 106. Nordion Recent Development
Table 107. C. R. Bard Company Details
Table 108. C. R. Bard Business Overview
Table 109. C. R. Bard Pituitary Cancer Product
Table 110. C. R. Bard Revenue in Pituitary Cancer Business (2016-2021) & (US$ Million)
Table 111. C. R. Bard Recent Development
Table 112. Isoray Medical Company Details
Table 113. Isoray Medical Business Overview
Table 114. Isoray Medical Pituitary Cancer Product
Table 115. Isoray Medical Revenue in Pituitary Cancer Business (2016-2021) & (US$ Million)
Table 116. Isoray Medical Recent Development
Table 117. RaySearch Laboratories Company Details
Table 118. RaySearch Laboratories Business Overview
Table 119. RaySearch Laboratories Pituitary Cancer Product
Table 120. RaySearch Laboratories Revenue in Pituitary Cancer Business (2016-2021) & (US$ Million)
Table 121. RaySearch Laboratories Recent Development
Table 122. Mevion Medical Systems Company Details
Table 123. Mevion Medical Systems Business Overview
Table 124. Mevion Medical Systems Pituitary Cancer Product
Table 125. Mevion Medical Systems Revenue in Pituitary Cancer Business (2016-2021) & (US$ Million)
Table 126. Mevion Medical Systems Recent Development
Table 127. Mitsubishi Electric Company Details
Table 128. Mitsubishi Electric Business Overview
Table 129. Mitsubishi Electric Pituitary Cancer Product
Table 130. Mitsubishi Electric Revenue in Pituitary Cancer Business (2016-2021) & (US$ Million)
Table 131. Mitsubishi Electric Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pituitary Cancer Market Share by Type: 2020 VS 2027
Figure 2. Blood Tests Features
Figure 3. Urine Test Features
Figure 4. Brain Imaging Features
Figure 5. Vision Testing Features
Figure 6. Global Pituitary Cancer Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinics Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Pituitary Cancer Report Years Considered
Figure 12. Global Pituitary Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Pituitary Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Pituitary Cancer Market Share by Regions: 2020 VS 2027
Figure 15. Global Pituitary Cancer Market Share by Regions (2022-2027)
Figure 16. Global Pituitary Cancer Market Share by Players in 2020
Figure 17. Global Top Pituitary Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pituitary Cancer as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Pituitary Cancer Revenue in 2020
Figure 19. Global Pituitary Cancer Revenue Market Share by Type (2016-2021)
Figure 20. Global Pituitary Cancer Revenue Market Share by Type (2022-2027)
Figure 21. North America Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Pituitary Cancer Market Share by Type (2016-2027)
Figure 23. North America Pituitary Cancer Market Share by Application (2016-2027)
Figure 24. North America Pituitary Cancer Market Share by Country (2016-2027)
Figure 25. United States Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Pituitary Cancer Market Share by Type (2016-2027)
Figure 29. Europe Pituitary Cancer Market Share by Application (2016-2027)
Figure 30. Europe Pituitary Cancer Market Share by Country (2016-2027)
Figure 31. Germany Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Pituitary Cancer Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Pituitary Cancer Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Pituitary Cancer Market Share by Region (2016-2027)
Figure 41. China Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Pituitary Cancer Market Share by Type (2016-2027)
Figure 49. Latin America Pituitary Cancer Market Share by Application (2016-2027)
Figure 50. Latin America Pituitary Cancer Market Share by Country (2016-2027)
Figure 51. Mexico Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Pituitary Cancer Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Pituitary Cancer Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Pituitary Cancer Market Share by Country (2016-2027)
Figure 57. Turkey Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Pituitary Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Trinity Biotech Revenue Growth Rate in Pituitary Cancer Business (2016-2021)
Figure 61. Salzman Revenue Growth Rate in Pituitary Cancer Business (2016-2021)
Figure 62. Genentech Revenue Growth Rate in Pituitary Cancer Business (2016-2021)
Figure 63. Sigma-Aldrich Revenue Growth Rate in Pituitary Cancer Business (2016-2021)
Figure 64. Varian Medical Systems Revenue Growth Rate in Pituitary Cancer Business (2016-2021)
Figure 65. Elekta Revenue Growth Rate in Pituitary Cancer Business (2016-2021)
Figure 66. Accuray Incorporated Revenue Growth Rate in Pituitary Cancer Business (2016-2021)
Figure 67. Ion Beam Applications Revenue Growth Rate in Pituitary Cancer Business (2016-2021)
Figure 68. Nordion Revenue Growth Rate in Pituitary Cancer Business (2016-2021)
Figure 69. C. R. Bard Revenue Growth Rate in Pituitary Cancer Business (2016-2021)
Figure 70. Isoray Medical Revenue Growth Rate in Pituitary Cancer Business (2016-2021)
Figure 71. RaySearch Laboratories Revenue Growth Rate in Pituitary Cancer Business (2016-2021)
Figure 72. Mevion Medical Systems Revenue Growth Rate in Pituitary Cancer Business (2016-2021)
Figure 73. Mitsubishi Electric Revenue Growth Rate in Pituitary Cancer Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

---